Zura Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2022
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Mar '22 Mar 31, 2022
Cash & Equivalents	139.02	176.5	99.81	1.57	4.72
Cash & Short-Term Investments	139.02	176.5	99.81	1.57	4.72
Cash Growth	-26.14%	76.84%	6269.24%	-66.80%	-
Prepaid Expenses	3.28	2.25	1.04	0.21	-
Total Current Assets	142.29	178.74	100.84	1.78	4.72
Property, Plant & Equipment	0.13	0.09	-	-	-
Long-Term Deferred Charges	-	-	-	3.49	-
Other Long-Term Assets	1.51	0.7	-	-	-
Total Assets	143.94	179.53	100.84	5.26	4.72
Accounts Payable	3.28	0.73	2.75	2.01	0.01
Accrued Expenses	12.22	9.28	7.55	0.82	-
Short-Term Debt	-	-	-	7.76	-
Other Current Liabilities	10	9.5	10	4.23	0.03
Total Current Liabilities	25.49	19.51	20.3	14.82	0.04
Other Long-Term Liabilities	-	-	0.99	-	-
Total Liabilities	25.49	19.51	21.29	14.82	0.04
Common Stock	0.01	0.01	0	-	-
Additional Paid-In Capital	315.61	302.71	162.82	-	-
Retained Earnings	-207.37	-155.9	-103.49	-32.06	-7.82
Total Common Equity	108.24	146.82	59.33	-32.06	-7.82
Minority Interest	10.2	13.2	20.22	10	-
Shareholders' Equity	118.44	160.02	79.55	-9.56	4.68
Total Liabilities & Equity	143.94	179.53	100.84	5.26	4.72
Total Debt	-	-	-	7.76	-
Net Cash (Debt)	139.02	176.5	99.81	-6.19	4.72
Net Cash Growth	-26.14%	76.84%	-	-	-
Net Cash Per Share	1.49	2.35	3.02	-27.13	-
Filing Date Shares Outstanding	65.02	68.37	43.59	43.09	17.25
Total Common Shares Outstanding	65.02	65.3	43.59	0.38	17.25
Working Capital	116.8	159.23	80.54	-13.04	4.68
Book Value Per Share	1.66	2.25	1.36	-83.59	-0.45
Tangible Book Value	108.24	146.82	59.33	-32.06	-7.82
Tangible Book Value Per Share	1.66	2.25	1.36	-83.59	-0.45

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q